From the Department of Anesthesiology, National Taiwan University Hospital, Taipei, Taiwan.
Virginia Tech, Center for Gerontology, Blacksburg, Virginia.
Anesth Analg. 2021 Sep 1;133(3):765-771. doi: 10.1213/ANE.0000000000005482.
Postoperative delirium is common among older surgical patients and may be associated with anesthetic management during the perioperative period. The aim of this study is to assess whether intravenous midazolam, a short-acting benzodiazepine used frequently as premedication, increased the incidence of postoperative delirium.
Analyses of existing data were conducted using a database created from 3 prospective studies in patients aged 65 years or older who underwent elective major noncardiac surgery. Postoperative delirium occurring on the first postoperative day was measured using the confusion assessment method. We assessed the association between the use or nonuse of premedication with midazolam and postoperative delirium using a χ2 test, using propensity scores to match up with 3 midazolam patients for each control patient who did not receive midazolam.
A total of 1266 patients were included in this study. Intravenous midazolam was administered as premedication in 909 patients (72%), and 357 patients did not receive midazolam. Those who did and did not receive midazolam significantly differed in age, Charlson comorbidity scores, preoperative cognitive status, preoperative use of benzodiazepines, type of surgery, and year of surgery. Propensity score matching for these variables and American Society of Anesthesiology physical status scores resulted in propensity score-matched samples with 1-3 patients who used midazolam (N = 749) for each patient who did not receive midazolam (N = 357). After propensity score matching, all standardized differences in preoperative patient characteristics ranged from -0.07 to 0.06, indicating good balance on baseline variables between the 2 exposure groups. No association was found between premedication with midazolam and incident delirium on the morning of the first postoperative day in the matched dataset, with odds ratio (95% confidence interval) of 0.91 (0.65-1.29), P = .67.
Premedication using midazolam was not associated with higher incidence of delirium on the first postoperative day in older patients undergoing major noncardiac surgery.
术后谵妄在老年手术患者中很常见,可能与围手术期的麻醉管理有关。本研究旨在评估作为术前用药广泛使用的短效苯二氮䓬类药物咪达唑仑是否会增加术后谵妄的发生率。
使用从 3 项针对 65 岁及以上择期非心脏大手术患者的前瞻性研究中创建的数据库对现有数据进行分析。使用意识模糊评估法评估术后第一天发生的术后谵妄。使用 χ2 检验评估使用或不使用咪达唑仑进行术前用药与术后谵妄之间的关联,并使用倾向评分将每个未接受咪达唑仑的对照患者与 3 名接受咪达唑仑的患者相匹配。
本研究共纳入 1266 名患者。909 名患者(72%)接受咪达唑仑作为术前用药,357 名患者未接受咪达唑仑。接受和未接受咪达唑仑的患者在年龄、Charlson 合并症评分、术前认知状态、术前使用苯二氮䓬类药物、手术类型和手术年份方面存在显著差异。对这些变量和美国麻醉医师协会身体状况评分进行倾向评分匹配,结果为每个未接受咪达唑仑的患者(n=357)匹配 1-3 名使用咪达唑仑的患者(n=749),得到倾向评分匹配样本。在倾向评分匹配后,所有术前患者特征的标准化差异均在-0.07 至 0.06 之间,表明两组之间的基线变量平衡良好。在匹配数据集上,咪达唑仑术前用药与术后第一天清晨发生谵妄之间无关联,比值比(95%置信区间)为 0.91(0.65-1.29),P=0.67。
在接受非心脏大手术的老年患者中,咪达唑仑术前用药与术后第一天谵妄发生率升高无关。